
This McKinsey article argues that the medtech industry must immediately adopt omnichannel engagement models to better connect with healthcare professionals (HCPs) and other stakeholders, ultimately improving patient care.
The COVID-19 pandemic accelerated a shift towards digital interactions, with HCPs now preferring hybrid engagement, blending in-person contact with digital channels like email and video calls for information and product ordering.
To successfully implement this, medtech companies need a systematic approach: setting a clear vision, using design thinking to understand stakeholder needs, establishing agile cross-functional teams, building a robust analytics engine, developing a scalable technology infrastructure, and preparing their organisation for significant change by hiring new talent and upskilling existing staff.
Related Articles
Beyond the Mass Email: The Imperative of Personalization in Pharma
Why HCPs are tuning out generic communications and how personalization is transforming engagement.
Pharma Marketing: What's Working for HCPs in 2025
Key insights from pharma marketing leaders on effective HCP engagement strategies.
How Omnichannel is Transforming Pharma Engagement
The digital transformation journey and its impact on healthcare provider relationships.